Pamisell has ranked among the top searched stocks for 5 days in the past month.


As of 9:30 AM on the 11th, Pamisell is trading at 20,450 KRW, down 1.45% from the previous day. This represents a 9.91% decrease compared to August 26. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Over the past 5 days, individual investors have net purchased 54,621 shares, while foreigners and institutions have net purchased 61,471 shares and net sold 23,049 shares, respectively.



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing